Next Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic Perspective
Preprint
- 10 May 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Increasing clinical and preclinical evidences implicate gut microbiome (GM) dysbiosis as a key susceptibility factor for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s diseases (PD). In recent years, neurodegenerative diseases have not been viewed as driven solely by defects in brain, and the role of GM in modulating the central nervous system function via gut-brain axis has attracted considerable interest. Encouraged by GM researches, the next-generation probiotics may lead to tangible impacts on the treatment of neurodegenerative disorders. This review summarizes the current understandings of GM composition and characteristics associated with neurodegenerative diseases, and the demonstrations of molecules from GM affecting neurodegeneration. Particularly, applications of next-generation probiotics such as Clostridium butyricum, Akkermansia muciniphila, Faecalibacterium prausnitzii, and Bacteroides fragilis for remediation of neurodegenerative diseases are discussed.Keywords
All Related Versions
- Version 1, 2023-05-10, Preprints
- Published version: Microorganisms, 11 (6), 1527.
This publication has 84 references indexed in Scilit:
- Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCCHepatology, 2022
- Effect of Clostridium butyricum against Microglia‐Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites ButyrateMolecular Nutrition & Food Research, 2019
- Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?Acta Neuropathologica, 2018
- Of genes and microbes: solving the intricacies in host genomesProtein & Cell, 2018
- The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorderMovement Disorders, 2017
- Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical featuresScience China Life Sciences, 2017
- Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiomeMovement Disorders, 2017
- Alpha‐synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarkerMovement Disorders, 2015
- Colonic bacterial composition in Parkinson's diseaseMovement Disorders, 2015
- Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in ratsActa Neuropathologica, 2014